RxDoctor Payments Data

Chirag Patel, MD

Retina Specialist · Columbus, OHNPI 1124224936

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 125 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 28.4% of the total. That places this record below the midpoint for retina specialist clinicians in OH, where the typical reported total is $4,390.

$2,651in general payments, 2019–2025

Across 125 payments — averaging $21.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$752
  • Genentech USA, Inc.$592
  • AbbVie$216
  • Astellas Pharma US Inc$208
  • Apellis Pharmaceuticals, Inc.$189
  • Dutch Ophthalmic, USA$177
  • plus $516 from 8 others

What the payments were for

  • Food & beverage$2,651100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,651 in reported general payments places this provider in the 40th percentile of 69 retina specialist providers in Ohio.

See all retina specialist providers in Ohio

Medicare billing

Part B allowed, 2024
$3,171,987
Medicare patients
787
Services billed
17,920

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LumiganBimatoprost21$9,484
Prednisolone Acetate220$7,325
Atropine Sulfate102$2,872
Brimonidine Tartrate70$2,728
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat45$621
Ciprofloxacin Hcl63$529
Ofloxacin50$528
Latanoprost61$377
Dorzolamide Hcl11$339
MethotrexateMethotrexate Sodium29$323
ErythromycinErythromycin Base28$216
Timolol Maleate25$119
Ibuprofen12$21

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLumigan$216$9,48421 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 69 retina specialist providers in Ohio.

Other retina specialist in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →